Abecma (Idecabtagene vicleucel)

Overview
Abecma is a therapy approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma after four or more prior therapies, including an immunomodulatory agent,… read more

Adriamycin (Doxorubicin)

The Adriamycin brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to… read more

Alkeran (Melphalan)

The Alkeran brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your…

Aredia (Pamidronate)

Overview
Aredia is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat and prevent osteolytic (bone) lesions caused by multiple myeloma. Some doctors may also prescribe Aredia for people… read more

Autologous (self) stem cell transplant

Overview
Stem cell transplant after high-dose chemotherapy is the most common treatment for people when first diagnosed with multiple myeloma. The purpose of a stem cell transplant in multiple myeloma is to replace… read more

BiCNU (Carmustine)

Overview
BiCNU is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating multiple myeloma and other cancers. BiCNU is often combined with other drugs such as corticosteroids.… read more

Blenrep (Belantamab Mafodotin-Blmf) for Multiple Myeloma

Blenrep (belantamab mafodotin-blmf) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsed or refractory…

Boruzu (Bortezomib)

Overview
Boruzu is approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma. It may be used as an initial treatment or as part of retreatment if the disease returns. Eligibility…

Carvykti (Ciltacabtagene Autoleucel) for Multiple Myeloma

Carvykti (ciltacabtagene autoleucel) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Cytoxan (Cyclophosphamide)

The Cytoxan brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more

Darzalex (Daratumumab) for Multiple Myeloma

Darzalex (daratumumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Darzalex Faspro (Daratumumab and Hyaluronidase-Fihj)

Overview
Darzalex Faspro is approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma in adults. This treatment is used in combination with other drugs such as bortezomib, lenalidomide…

Doxil (Doxorubicin liposomal)

Overview

Doxil is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating cancers including multiple myeloma. In cases of myeloma, Doxil is usually combined with Velcade and…

Elrexfio (Elranatamab-Bcmm) for Multiple Myeloma

Elrexfio (elranatamab-bcmm) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Empliciti (Elotuzumab) for Multiple Myeloma

Empliciti (elotuzumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma in combination…

Evomela (Melphalan)

Overview
Evomela is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating multiple myeloma. Evomela is often combined with other drugs such as Velcade or Thalomid and a corticost… read more

Farydak (Panobinostat)

The Farydak brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more

Kyprolis (Carfilzomib)

Overview
Kyprolis is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat multiple myeloma in people who have tried other therapies. Kyprolis is often combined with a corticosteroid… read more

Lynozyfic (Linvoseltamab-Gcpt)

Overview
Lynozyfic is approved by the U.S. Food and Drug Administration (FDA) under accelerated approval for adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy…

Mozobil (Plerixafor)

Overview
Mozobil is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat multiple myeloma and non-Hodgkin lymphoma. Mozobil is also known by its drug name, plerixafor.

Mozobil is a… read more

Ninlaro (Ixazomib) for Multiple Myeloma

Ninlaro (ixazomib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Osenvelt (Denosumab-Bmwo)

Overview
Osenvelt is approved by the U.S. Food and Drug Administration (FDA) to prevent skeletal-related events in people with multiple myeloma and in those with bone metastases from solid tumors. Skeletal-related events…

Pomalyst (Pomalidomide)

Overview
Pomalyst is a prescription medication approved by the Food and Drug Administration (FDA) to treat multiple myeloma that has progressed after being treated with other therapies. Pomalyst is often combined with a… read more

Radiation therapy

Overview
Radiation therapy (also called radiotherapy) is commonly used to treat solitary plasmacytoma – an early stage of multiple myeloma involving a single lesion in the bone or soft tissues. Plasmacytoma that occurs… read more

Revlimid (Lenalidomide)

Overview
Revlimid is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat multiple myeloma. Revlimid is often combined with a corticosteroid like dexamethasone to treat newly… read more

Sarclisa (Isatuximab-Irfc) for Multiple Myeloma

Sarclisa (isatuximab-irfc) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with multiple myeloma. It is used with…

Talvey (Talquetamab-Tgvs) for Myeloma

Talvey is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have already tried at least four…

Tecvayli (Teclistamab-Cqyv) for Myeloma

Overview
Tecvayli is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with relapsed or refractory multiple myeloma. It may be used in combination with daratumumab hyaluronidase-fihj in…

Velcade (Bortezomib)

Overview
Velcade is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating multiple myeloma. Velcade is often combined with a corticosteroid and other drugs such as Cytoxan, Revli… read more

Xbryk (Denosumab-Dssb)

Overview
Xbryk (denosumab-dssb) is approved by the U.S. Food and Drug Administration (FDA) to help prevent skeletal-related events in people with multiple myeloma or bone metastases from solid tumors. These events can…

Xgeva (Denosumab) for Multiple Myeloma

Xgeva (denosumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for preventing skeletal-related events in adults with multiple…

Xpovio (Selinexor) for Multiple Myeloma

What Members SayTop TipsSide EffectsCopay HelpFAQs

Xpovio (selinexor) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with multiple myeloma. It is used with other…

Zometa (Zoledronic acid)

The Zometa brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more